Synopsis
Synopsis
0
EU WC
0
VMF
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Chloride, Magnesium
2. Magnesium Chloride
3. Mgcl2
1. Magnesium Dichloride Hexahydrate
2. Bischofite
3. Polycatan
4. Magnesia Muriatica
5. Magnesium Chloride, Hexahydrate
6. Ccris 3494
7. Magnesium;dichloride;hexahydrate
8. Bischofite (mgcl2.6h2o)
9. Chlorure De Magnesium Hydrate
10. Magnesium Chloride Hydrate (mgcl2.6h2o)
11. Ins No.511
12. Chebi:86345
13. Ins-511
14. 02f3473h9o
15. E-511
16. Chlorure De Magnesium Hydrate [french]
17. Mgcl2.6h2o
18. Magnesium Chloride [usp]
19. Magnesium Chloride [ii]
20. Chembl3185229
21. Dtxsid0020789
22. Magnesium Chloride [fcc]
23. Magnesium Chloride [jan]
24. Unii-02f3473h9o
25. Magnesia Muriatica [hpus]
26. Magnesium Chloride [inci]
27. Magnesium Chloride [vandf]
28. Magnesium(ii)-chloride Hexahydrate
29. Magnesium Chloride [usp-rs]
30. Magnesium Dichloride--water (1/6)
31. Akos015855540
32. Magnesium Chloride [orange Book]
33. Ncgc00248737-01
34. Magnesium Chloride [usp Monograph]
35. Magnesium(ii) Chloride Hexahydrate
36. Magnesium Chloride Hexahydrate [mi]
37. Ft-0628076
38. Magnesium Chloride Hexahydrate A.c.s.reagent
39. Normocarb Component Magnesium Chloride
40. Magnesium Chloride Hexahydrate [who-dd]
41. Magnesium Chloride Component Of Normocarb
42. Magnesium Chloride Hexahydrate 46.5% Min Mgcl2
43. Magnesium Chloride Hexahydrate [ep Monograph]
44. Q19364448
45. 13778-96-6
| Molecular Weight | 203.30 g/mol |
|---|---|
| Molecular Formula | Cl2H12MgO6 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 0 |
| Exact Mass | 201.9861352 g/mol |
| Monoisotopic Mass | 201.9861352 g/mol |
| Topological Polar Surface Area | 6 Ų |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Complexity | 0 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 9 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41553
Submission : 2025-07-07
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41537
Submission : 2025-07-07
Status : Active
Type : IV

GDUFA
DMF Review : Complete
Rev. Date : 2019-02-05
Pay. Date : 2019-01-30
DMF Number : 20488
Submission : 2007-04-26
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2018-10-10
Pay. Date : 2015-05-05
DMF Number : 17834
Submission : 2004-11-16
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25841
Submission : 2011-11-22
Status : Active
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Registration Number : 305MF10009
Registrant's Address : Zahradni(') 46c,792 01 Brunta(')l, Czech Republic
Initial Date of Registration : 2023-01-18
Latest Date of Registration : 2023-01-18

Registration Number : 223MF10150
Registrant's Address : Zahradni(') 46c,792 01 Brunta(')l, Czech Republic
Initial Date of Registration : 2011-10-14
Latest Date of Registration : 2020-08-27

Magnesium chloride (for manufacturing purposes only)
Registration Number : 217MF10674
Registrant's Address : 92 Minookicho, Fukuyama City, Hiroshima Prefecture
Initial Date of Registration : 2005-10-07
Latest Date of Registration : 2006-12-28

Japanese Pharmacopoeia Non-Drug Standards Magnesium Chloride
Registration Number : 230MF10112
Registrant's Address : 85-1 Maruyama, Myojin, Setocho, Naruto City, Tokushima Prefecture
Initial Date of Registration : 2018-08-20
Latest Date of Registration : 2018-08-20

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.
About the Company : Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 s...
About the Company : Brenntag is the global market leader in providing a full range of chemicals and ingredients and value-added services. By connecting chemical manufacturers (our suppliers) and chemi...

Magnesium Chloride Hexahydrate
About the Company : The Lehrte chemical factory can look back on a tradition of more than 130 years at the Lehrte site and has a correspondingly large amount of experience in the production of inorgan...

About the Company : India Phosphate, established in 2007, is a leading processor, exporter, and supplier of high-quality Calcium Phosphate. Known for its purity, accuracy, and cost-effectiveness, our ...

Magnesium Chloride Hexahydrate
About the Company : Macco Organiques, s.r.o. in the Czech Republic is a prominent producer and supplier of inorganic salts utilized in various industries, including IV and dialysis solutions, pharmace...

About the Company : Nandu Group consisting of Nandu Chemical Industries, Nandu Chemicals Private Limited and Nandu Pharma Private Limited has a diversified product range to serve multiple applications...

About the Company : Nitika Pharmaceutical Specialities was found in 1991 as a small manufacturing unit has grown today into a dynamic production center for a range of products finding applications in ...

About the Company : Valaji PharmaChem is an ISO certified and a leading name in the field of Fine/ Specialty high purity chemicals with large manufacturing facilities located at Padra, Baroda, Gujarat...

About the Company : VM Chemicals is one of the topmost Manufacturers, Exporters and Wholesale Suppliers of a wide gamut of Chemicals like Sodium Chloride IP BP, Sodium Bicarbonate IP BP, Sodium Acetat...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
11
PharmaCompass offers a list of Magnesium Chloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Magnesium Chloride manufacturer or Magnesium Chloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Magnesium Chloride manufacturer or Magnesium Chloride supplier.
PharmaCompass also assists you with knowing the Magnesium Chloride API Price utilized in the formulation of products. Magnesium Chloride API Price is not always fixed or binding as the Magnesium Chloride Price is obtained through a variety of data sources. The Magnesium Chloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A PLASMA-LYTE A IN PLASTIC CONTAINER manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of PLASMA-LYTE A IN PLASTIC CONTAINER, including repackagers and relabelers. The FDA regulates PLASMA-LYTE A IN PLASTIC CONTAINER manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. PLASMA-LYTE A IN PLASTIC CONTAINER API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of PLASMA-LYTE A IN PLASTIC CONTAINER manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A PLASMA-LYTE A IN PLASTIC CONTAINER supplier is an individual or a company that provides PLASMA-LYTE A IN PLASTIC CONTAINER active pharmaceutical ingredient (API) or PLASMA-LYTE A IN PLASTIC CONTAINER finished formulations upon request. The PLASMA-LYTE A IN PLASTIC CONTAINER suppliers may include PLASMA-LYTE A IN PLASTIC CONTAINER API manufacturers, exporters, distributors and traders.
click here to find a list of PLASMA-LYTE A IN PLASTIC CONTAINER suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A PLASMA-LYTE A IN PLASTIC CONTAINER DMF (Drug Master File) is a document detailing the whole manufacturing process of PLASMA-LYTE A IN PLASTIC CONTAINER active pharmaceutical ingredient (API) in detail. Different forms of PLASMA-LYTE A IN PLASTIC CONTAINER DMFs exist exist since differing nations have different regulations, such as PLASMA-LYTE A IN PLASTIC CONTAINER USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A PLASMA-LYTE A IN PLASTIC CONTAINER DMF submitted to regulatory agencies in the US is known as a USDMF. PLASMA-LYTE A IN PLASTIC CONTAINER USDMF includes data on PLASMA-LYTE A IN PLASTIC CONTAINER's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The PLASMA-LYTE A IN PLASTIC CONTAINER USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of PLASMA-LYTE A IN PLASTIC CONTAINER suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The PLASMA-LYTE A IN PLASTIC CONTAINER Drug Master File in Japan (PLASMA-LYTE A IN PLASTIC CONTAINER JDMF) empowers PLASMA-LYTE A IN PLASTIC CONTAINER API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the PLASMA-LYTE A IN PLASTIC CONTAINER JDMF during the approval evaluation for pharmaceutical products. At the time of PLASMA-LYTE A IN PLASTIC CONTAINER JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of PLASMA-LYTE A IN PLASTIC CONTAINER suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a PLASMA-LYTE A IN PLASTIC CONTAINER Drug Master File in Korea (PLASMA-LYTE A IN PLASTIC CONTAINER KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of PLASMA-LYTE A IN PLASTIC CONTAINER. The MFDS reviews the PLASMA-LYTE A IN PLASTIC CONTAINER KDMF as part of the drug registration process and uses the information provided in the PLASMA-LYTE A IN PLASTIC CONTAINER KDMF to evaluate the safety and efficacy of the drug.
After submitting a PLASMA-LYTE A IN PLASTIC CONTAINER KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their PLASMA-LYTE A IN PLASTIC CONTAINER API can apply through the Korea Drug Master File (KDMF).
click here to find a list of PLASMA-LYTE A IN PLASTIC CONTAINER suppliers with KDMF on PharmaCompass.
A PLASMA-LYTE A IN PLASTIC CONTAINER CEP of the European Pharmacopoeia monograph is often referred to as a PLASMA-LYTE A IN PLASTIC CONTAINER Certificate of Suitability (COS). The purpose of a PLASMA-LYTE A IN PLASTIC CONTAINER CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of PLASMA-LYTE A IN PLASTIC CONTAINER EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of PLASMA-LYTE A IN PLASTIC CONTAINER to their clients by showing that a PLASMA-LYTE A IN PLASTIC CONTAINER CEP has been issued for it. The manufacturer submits a PLASMA-LYTE A IN PLASTIC CONTAINER CEP (COS) as part of the market authorization procedure, and it takes on the role of a PLASMA-LYTE A IN PLASTIC CONTAINER CEP holder for the record. Additionally, the data presented in the PLASMA-LYTE A IN PLASTIC CONTAINER CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the PLASMA-LYTE A IN PLASTIC CONTAINER DMF.
A PLASMA-LYTE A IN PLASTIC CONTAINER CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. PLASMA-LYTE A IN PLASTIC CONTAINER CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of PLASMA-LYTE A IN PLASTIC CONTAINER suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing PLASMA-LYTE A IN PLASTIC CONTAINER as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for PLASMA-LYTE A IN PLASTIC CONTAINER API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture PLASMA-LYTE A IN PLASTIC CONTAINER as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain PLASMA-LYTE A IN PLASTIC CONTAINER and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a PLASMA-LYTE A IN PLASTIC CONTAINER NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of PLASMA-LYTE A IN PLASTIC CONTAINER suppliers with NDC on PharmaCompass.
PLASMA-LYTE A IN PLASTIC CONTAINER Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of PLASMA-LYTE A IN PLASTIC CONTAINER GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right PLASMA-LYTE A IN PLASTIC CONTAINER GMP manufacturer or PLASMA-LYTE A IN PLASTIC CONTAINER GMP API supplier for your needs.
A PLASMA-LYTE A IN PLASTIC CONTAINER CoA (Certificate of Analysis) is a formal document that attests to PLASMA-LYTE A IN PLASTIC CONTAINER's compliance with PLASMA-LYTE A IN PLASTIC CONTAINER specifications and serves as a tool for batch-level quality control.
PLASMA-LYTE A IN PLASTIC CONTAINER CoA mostly includes findings from lab analyses of a specific batch. For each PLASMA-LYTE A IN PLASTIC CONTAINER CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
PLASMA-LYTE A IN PLASTIC CONTAINER may be tested according to a variety of international standards, such as European Pharmacopoeia (PLASMA-LYTE A IN PLASTIC CONTAINER EP), PLASMA-LYTE A IN PLASTIC CONTAINER JP (Japanese Pharmacopeia) and the US Pharmacopoeia (PLASMA-LYTE A IN PLASTIC CONTAINER USP).